Cargando…
Scaling Up Programmatic Management of Drug-Resistant Tuberculosis: A Prioritized Research Agenda
Frank Cobelens and colleagues outline key research questions that need to be addressed to maximize the impact of programmatic management of drug-resistant tuberculosis.
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2443187/ https://www.ncbi.nlm.nih.gov/pubmed/18613746 http://dx.doi.org/10.1371/journal.pmed.0050150 |
| _version_ | 1782156809326297088 |
|---|---|
| author | Cobelens, Frank G. J Heldal, Einar Kimerling, Michael E Mitnick, Carole D Podewils, Laura J Ramachandran, Rajeswari Rieder, Hans L Weyer, Karin Zignol, Matteo |
| author_facet | Cobelens, Frank G. J Heldal, Einar Kimerling, Michael E Mitnick, Carole D Podewils, Laura J Ramachandran, Rajeswari Rieder, Hans L Weyer, Karin Zignol, Matteo |
| author_sort | Cobelens, Frank G. J |
| collection | PubMed |
| description | Frank Cobelens and colleagues outline key research questions that need to be addressed to maximize the impact of programmatic management of drug-resistant tuberculosis. |
| format | Text |
| id | pubmed-2443187 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2008 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-24431872008-07-29 Scaling Up Programmatic Management of Drug-Resistant Tuberculosis: A Prioritized Research Agenda Cobelens, Frank G. J Heldal, Einar Kimerling, Michael E Mitnick, Carole D Podewils, Laura J Ramachandran, Rajeswari Rieder, Hans L Weyer, Karin Zignol, Matteo PLoS Med Guidelines and Guidance Frank Cobelens and colleagues outline key research questions that need to be addressed to maximize the impact of programmatic management of drug-resistant tuberculosis. Public Library of Science 2008-07 2008-07-08 /pmc/articles/PMC2443187/ /pubmed/18613746 http://dx.doi.org/10.1371/journal.pmed.0050150 Text en This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. |
| spellingShingle | Guidelines and Guidance Cobelens, Frank G. J Heldal, Einar Kimerling, Michael E Mitnick, Carole D Podewils, Laura J Ramachandran, Rajeswari Rieder, Hans L Weyer, Karin Zignol, Matteo Scaling Up Programmatic Management of Drug-Resistant Tuberculosis: A Prioritized Research Agenda |
| title | Scaling Up Programmatic Management of Drug-Resistant Tuberculosis: A Prioritized Research Agenda |
| title_full | Scaling Up Programmatic Management of Drug-Resistant Tuberculosis: A Prioritized Research Agenda |
| title_fullStr | Scaling Up Programmatic Management of Drug-Resistant Tuberculosis: A Prioritized Research Agenda |
| title_full_unstemmed | Scaling Up Programmatic Management of Drug-Resistant Tuberculosis: A Prioritized Research Agenda |
| title_short | Scaling Up Programmatic Management of Drug-Resistant Tuberculosis: A Prioritized Research Agenda |
| title_sort | scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda |
| topic | Guidelines and Guidance |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2443187/ https://www.ncbi.nlm.nih.gov/pubmed/18613746 http://dx.doi.org/10.1371/journal.pmed.0050150 |
| work_keys_str_mv | AT cobelensfrankgj scalingupprogrammaticmanagementofdrugresistanttuberculosisaprioritizedresearchagenda AT heldaleinar scalingupprogrammaticmanagementofdrugresistanttuberculosisaprioritizedresearchagenda AT kimerlingmichaele scalingupprogrammaticmanagementofdrugresistanttuberculosisaprioritizedresearchagenda AT mitnickcaroled scalingupprogrammaticmanagementofdrugresistanttuberculosisaprioritizedresearchagenda AT podewilslauraj scalingupprogrammaticmanagementofdrugresistanttuberculosisaprioritizedresearchagenda AT ramachandranrajeswari scalingupprogrammaticmanagementofdrugresistanttuberculosisaprioritizedresearchagenda AT riederhansl scalingupprogrammaticmanagementofdrugresistanttuberculosisaprioritizedresearchagenda AT weyerkarin scalingupprogrammaticmanagementofdrugresistanttuberculosisaprioritizedresearchagenda AT zignolmatteo scalingupprogrammaticmanagementofdrugresistanttuberculosisaprioritizedresearchagenda AT scalingupprogrammaticmanagementofdrugresistanttuberculosisaprioritizedresearchagenda |